10 Sept 2020
37m

Jason Springs On Selling His First Startup To Roche For $425 Million And Now Bringing Targeted Therapies To Critically Ill Patients

Podcast cover

DealMakers

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

Jason Springs On Selling His First Startup To Roche For $425 Million And Now Bringing Targeted Therapies To Critically Ill Patients